Centene Profit Rises in 1Q

Dow Jones
Apr 28
 

By Rob Curran

 

Centene's first-quarter earnings rose and the health insurer boosted its profit projections for the year as cost cuts and steady premium revenue growth offset rising medical expenses.

The St. Louis managed-care company posted earnings of $1.54 billion, or $3.11 a share, up from $1.31 billion, or $2.63 a share, a year earlier.

Stripping out certain one-time items, Centene logged adjusted earnings of $3.37 a share. Analysts polled by FactSet had anticipated adjusted earnings of $2.23 a share.

Revenue rose 7.1% to $49.94 billion, handily topping the Wall Street target of $47.53 billion, as tallied by FactSet.

Premium and service revenue rose 5.1% to $44.66 billion.

Centene's health-benefits ratio, a measure of how much was paid out to cover enrollees' medical expenses, was 87.3%, below the mean analyst estimate of 89.1%. Health insurers have been dogged by concerns of rising medical costs in recent quarters as an aging U.S. population avails of hospital and outpatient services at a growing pace.

"We continue to make tangible progress in our margin recovery efforts while strengthening the fundamental operations of each of our businesses," said Chief Executive Sarah London in a statement.

The company boosted its projection for 2026 per-share earnings to more than $2.37 from the previous $1.98 or higher. Centene also ratcheted up its forecast for adjusted earnings to greater than $3.40 a share from a prior estimate of more than $3 a share.

Centene boosted its 2026 revenue target, and now anticipates a range between $187.5 billion and $191.5 billion from a prior estimate of $186.5 billion to $190.5 billion, and compared with the analyst target of $188.8 billion. The company anticipates a health-benefits ratio between 90.9% and 91.7% for the year, in line with analysts' expectations of 91.4%.

Shares were up 2.3% to $44.50 in premarket trading.

 

Write to Rob Curran at rob.curran@dowjones.com

 

(END) Dow Jones Newswires

April 28, 2026 07:06 ET (11:06 GMT)

Copyright (c) 2026 Dow Jones & Company, Inc.

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10